28 Feb, EOD - Indian

SENSEX 73198.1 (-1.90)

Nifty 50 22124.7 (-1.86)

Nifty Bank 48344.7 (-0.82)

Nifty IT 37318.3 (-4.18)

Nifty Midcap 100 47915.2 (-2.49)

Nifty Next 50 57063.05 (-2.90)

Nifty Pharma 19813.5 (-1.92)

Nifty Smallcap 100 14700.2 (-3.01)

28 Feb, EOD - Global

NIKKEI 225 37155.5 (-2.88)

HANG SENG 22941.32 (-3.28)

S&P 5896.82 (0.52)

LOGIN HERE

companylogoPar Drugs & Chemicals Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 535341 | NSE Symbol : PAR | ISIN : INE04LG01015 | Industry : Pharmaceuticals - Indian - Bulk Drugs |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
05-Feb-2025 14-Feb-2025 Quarterly Results To consider and approve the financial results for the period ended December 31, 2024 and other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 14, 2025. (As Per NSE Announcement Dated on: 14.02.2025)
08-Jan-2025 11-Jan-2025 Change in Directors To consider other business matters Outcome of Board Meeting dated 11.01.2025 (As Per NSE Announcement Dated on: 11/01/2025)
27-Nov-2024 02-Dec-2024 EGM To consider other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on December 02, 2024 through Video Conferencing ('VC') mode. The Board meeting was commenced at 04:00 pm and concluded at 05:28 pm (As Per NSE Announcement Dated on: 02/12/2024)
11-Oct-2024 22-Oct-2024 Quarterly Results Financial Results/Other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on October 22, 2024. (As Per NSE Announcement Dated on: 22/10/2024)
09-Aug-2024 17-Aug-2024 AGM To consider other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 17, 2024. (As Per NSE Announcement Dated on: 17/08/2024)
24-Jul-2024 03-Aug-2024 Quarterly Results To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2024. Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2024. (As Per NSE Announcement Dated on: 03/08/2024)
29-Apr-2024 09-May-2024 Quarterly Results To consider other business matters. Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2024. Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024. (As Per NSE Announcement Dated on: 09/05/2024)
28-Feb-2024 07-Mar-2024 Others To consider other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 07, 2024. (As Per NSE Announcement Dated on: 07/03/2024)
06-Feb-2024 16-Feb-2024 Quarterly Results To consider and approve the financial results for the period ended December 31, 2023 and other business matters PAR : 16-Feb-2024 : The Company has informed the Exchange that a Board meeting to be held on February 14, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 16, 2024, To consider and approve the financial results for the period ended December 31, 2023 and other business matters (As Per NSE Announcement Dated on: 08/02/2024) Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 16, 2024. (As Per NSE Announcement Dated on: 16/02/2024)
19-Oct-2023 28-Oct-2023 Quarterly Results To consider and approve the financial results for the period ended September 30, 2023 and other business matters Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on October 28, 2023. (As Per NSE Announcement Dated on: 28/10/2023)
09-Aug-2023 17-Aug-2023 AGM To consider other business matters PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 17-Aug-2023 to consider Other business. Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 17, 2023. Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on August 17, 2023. (As Per NSE Announcement Dated on 17/08/2023)
25-Jul-2023 03-Aug-2023 Quarterly Results To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 03-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and Other business. Par Drugs And Chemicals Limited has informed the Exchange regarding 'Unaudited Standalone Financial Results of the Company for the quarter ended on 30th June, 2023 along with Limited Review Report'. Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2023. Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on August 03, 2023. Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2023. (As Per NSE Announcement Dated on 03/08/2023) Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication Standalone Unaudited Financial Results for the quarter ended 30th June, 2023 (As Per NSE Announcement Dated on 04/08/2023)
19-Apr-2023 27-Apr-2023 Accounts To consider and approve the financial results for the period ended March 31, 2023 and other business matters PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 27-Apr-2023 to consider financial statements for the period ended March 2023, Financial results/Other business. Re-appointment of Secretarial Auditor PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent Par Drugs And Chemicals Limited has informed the Exchange regarding 'Financial Result'. Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on April 27, 2023. Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on April 27, 2023. Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023. (As Per NSE Announcement Dated on 27/04/2023) Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication of Statement of Standalone Audited Financial Results for the Quarter and Year ended 31st March, 2023 (As Per NSE Announcement Dated on 28/04/2023)
02-Feb-2023 10-Feb-2023 Quarterly Results PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2023 to consider financial statements for the period ended December 2022, Financial results/Other business. Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 10, 2023. Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on February 10, 2023. Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022. (As Per NSE Announcement Dated on 10/02/2023) Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication of Standalone Unaudited Financial Results for the Quarter and Nine Month ended 31st December, 2022 (As Per NSE Announcement Dated on 11/02/2023)
27-Oct-2022 09-Nov-2022 Quarterly Results Par Drugs And Chemicals Limited has informed the Exchange about Board Meeting to be held on 09-Nov-2022 to consider financial statements for the period ended September 2022 and Other business matters Par Drugs And Chemicals Limited has informed the Exchange about Board Meeting held on 09-Nov-2022 to consider financial statements for the period ended September 2022 and Other business matters (As Per NSE Announcement Dated on 09.11.2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +